Decrease of tyrosine hydroxylase-, α-synuclein- and parkin-expressing neurons in the substantia nigra of MPTP-treated C57BL/6N mice

被引：0

作者：

Kitamura, Y ^{[1
]}

Sanada, H

Kakimura, J

Ishida, Y

Shimohama, S

Taniguchi, T

机构：

[1] Kyoto Pharmaceut Univ, Dept Neurobiol, Kyoto 6078412, Japan

[2] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068501, Japan

来源：

BIOGENIC AMINES | 2001年 / 16卷 / 02期

关键词：

MPTP; alpha-synuclein; parkin; tyrosine hydroxylase; substantia nigra; C57BL/6N mouse;

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Recently, mutations in the alpha -synuclein (PARK1) and parkin (PARK2) genes have been identified from patients with the familial Parkinson's disease and parkinsonism, respectively. Systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is known to damage the nigrostriatal dopaminergic system in C57BL/6 mice, in this study, we have investigated changes of immunoreactivities for alpha -synuclein, parkin and tyrosine hydroxylase (TH) in MPTP-treated C57BL/6N mouse brains. Immunoreactivities for alpha -synuclein, parkin and TH were differentially distributed in the mouse brain. MPTP treatment caused significant decrease of the number of TH-, alpha -synuclein- and parkin-immunopositive neurons in the substantia nigra, although these immunoreactivities were not markedly changed in the striatum. These results suggest that alpha -synuclein and parkin may participate in MPTP-induced dopaminergic neurodegeneration in the substantia nigra.

引用

页码：127 / 136

页数：10

共 29 条

[1]

Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO

[2]

2-E

[3] CHRONIC PARKINSONISM SECONDARY TO INTRAVENOUS-INJECTION OF MEPERIDINE ANALOGS [J].

DAVIS, GC ;

WILLIAMS, AC ;

MARKEY, SP ;

EBERT, MH ;

CAINE, ED ;

REICHERT, CM ;

KOPIN, IJ .

PSYCHIATRY RESEARCH, 1979, 1 (03) :249-254

[4] Prospects for new restorative and neuroprotective treatments in Parkinson's disease [J].

Dunnett, SB ;

Björklund, A .

NATURE, 1999, 399 (6738) :A32-A39

[5] Cloning of rat parkin cDNA and distribution of parkin in rat brain [J].

Gu, WJ ;

Abbas, N ;

Lagunes, MZ ;

Parent, A ;

Pradier, L ;

Bohme, GA ;

Agid, Y ;

Hirsch, EC ;

Raisman-Vozari, R ;

Brice, A .

JOURNAL OF NEUROCHEMISTRY, 2000, 74 (04) :1773-1776

[6]

Hashimoto M, 1999, BRAIN PATHOL, V9, P707

[7] The cDNA cloning and ontogeny of mouse α-synuclein [J].

Hong, L ;

Ko, HW ;

Gwag, BJ ;

Joe, E ;

Lee, S ;

Kim, YT ;

Suh, YH .

NEUROREPORT, 1998, 9 (06) :1239-1243

[8] Nitric oxide synthase and neuronal vulnerability in Parkinson's disease [J].

Hunot, S ;

Boissiere, F ;

Faucheux, B ;

Brugg, B ;

MouattPrigent, A ;

Agid, Y ;

Hirsch, EC .

NEUROSCIENCE, 1996, 72 (02) :355-363

[9] THE PRECURSOR PROTEIN OF NON-A-BETA COMPONENT OF ALZHEIMERS-DISEASE AMYLOID IS A PRESYNAPTIC PROTEIN OF THE CENTRAL-NERVOUS-SYSTEM [J].

IWAI, A ;

MASLIAH, E ;

YOSHIMOTO, M ;

GE, NF ;

FLANAGAN, L ;

DESILVA, HAR ;

KITTEL, A ;

SAITOH, T .

NEURON, 1995, 14 (02) :467-475

[10] Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism [J].

Kitada, T ;

Asakawa, S ;

Hattori, N ;

Matsumine, H ;

Yamamura, Y ;

Minoshima, S ;

Yokochi, M ;

Mizuno, Y ;

Shimizu, N .

NATURE, 1998, 392 (6676) :605-608

← 1 2 3 →